These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38127816)

  • 1. Autophagic dysfunction and gut microbiota dysbiosis cause chronic immune activation in a Drosophila model of Gaucher disease.
    Atilano ML; Hull A; Romila CA; Adams ML; Wildfire J; Ureña E; Dyson M; Ivan-Castillo-Quan J; Partridge L; Kinghorn KJ
    PLoS Genet; 2023 Dec; 19(12):e1011063. PubMed ID: 38127816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
    Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
    J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery.
    Hull A; Atilano ML; Gergi L; Kinghorn KJ
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220381. PubMed ID: 38368939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease.
    Kinghorn KJ; Asghari AM; Castillo-Quan JI
    Neural Regen Res; 2017 Mar; 12(3):380-384. PubMed ID: 28469644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between glucocerebrosidase mutations and Parkinson disease.
    Migdalska-Richards A; Schapira AH
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death by over-eating: The Gaucher disease associated gene GBA1, identified in a screen for mediators of autophagic cell death, is necessary for developmental cell death in Drosophila midgut.
    Dasari SK; Schejter E; Bialik S; Shkedy A; Levin-Salomon V; Levin-Zaidman S; Kimchi A
    Cell Cycle; 2017; 16(21):2003-2010. PubMed ID: 28933588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects,
    Zhao X; Lin Y; Liou B; Fu W; Jian J; Fannie V; Zhang W; Setchell KDR; Grabowski GA; Sun Y; Liu CJ
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2210442120. PubMed ID: 36574647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glitazone Treatment Rescues Phenotypic Deficits in a Fly Model of Gaucher/Parkinson's Disease.
    Shola-Dare O; Bailess S; Flores CC; Vanderheyden WM; Gerstner JR
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.
    Magalhaes J; Gegg ME; Migdalska-Richards A; Doherty MK; Whitfield PD; Schapira AH
    Hum Mol Genet; 2016 Aug; 25(16):3432-3445. PubMed ID: 27378698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
    Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
    Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.
    Kumar M; Srikanth MP; Deleidi M; Hallett PJ; Isacson O; Feldman RA
    Hum Mol Genet; 2023 May; 32(11):1888-1900. PubMed ID: 36752535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease.
    Yildiz Y; Hoffmann P; Vom Dahl S; Breiden B; Sandhoff R; Niederau C; Horwitz M; Karlsson S; Filocamo M; Elstein D; Beck M; Sandhoff K; Mengel E; Gonzalez MC; Nöthen MM; Sidransky E; Zimran A; Mattheisen M
    Orphanet J Rare Dis; 2013 Sep; 8():151. PubMed ID: 24070122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death.
    Keatinge M; Bui H; Menke A; Chen YC; Sokol AM; Bai Q; Ellett F; Da Costa M; Burke D; Gegg M; Trollope L; Payne T; McTighe A; Mortiboys H; de Jager S; Nuthall H; Kuo MS; Fleming A; Schapira AH; Renshaw SA; Highley JR; Chacinska A; Panula P; Burton EA; O'Neill MJ; Bandmann O
    Hum Mol Genet; 2015 Dec; 24(23):6640-52. PubMed ID: 26376862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GBA1 and The Immune System: A Potential Role in Parkinson's Disease?
    Al-Azzawi ZAM; Arfaie S; Gan-Or Z
    J Parkinsons Dis; 2022; 12(s1):S53-S64. PubMed ID: 36057834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's disease.
    Osellame LD; Rahim AA; Hargreaves IP; Gegg ME; Richard-Londt A; Brandner S; Waddington SN; Schapira AHV; Duchen MR
    Cell Metab; 2013 Jun; 17(6):941-953. PubMed ID: 23707074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.
    Johnson PH; Weinreb NJ; Cloyd JC; Tuite PJ; Kartha RV
    Mol Genet Metab; 2020 Feb; 129(2):35-46. PubMed ID: 31761523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher disease - more than just a rare lipid storage disease.
    Roh J; Subramanian S; Weinreb NJ; Kartha RV
    J Mol Med (Berl); 2022 Apr; 100(4):499-518. PubMed ID: 35066608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.
    Pitcairn C; Wani WY; Mazzulli JR
    Neurobiol Dis; 2019 Feb; 122():72-82. PubMed ID: 29550539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.
    Menozzi E; Toffoli M; Schapira AHV
    Pharmacol Ther; 2023 Jun; 246():108419. PubMed ID: 37080432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.